Galephar Pharmaceutical Research Inc401(k)
GALEPHAR PHARMACEUTICAL RETIREMENT PLAN · HUMACAO, PR · plan year 2023
Peer grade: C+ · admin costs + employer contributions vs same-size plans · how grading works
Galephar Pharmaceutical Research Inc reported $4,654 in plan administrative expenses for 2023: 2.10% of average plan assets, above the peer median. Employer contributions averaged $283 per active participant. This ratio covers administrative expenses reported on the plan's Schedule H only; fund-level expense ratios are not included in public structured data — see methodology.
The plan sits in the under $1M size bracket, benchmarked here against 1,192 comparable plans and shown alongside other professional & technical services employers. By assets it is among the smaller plans on file in PR (315th of 323), and 11,533rd of 11,654 in professional & technical services. In 2023, employees put in $5.13 for every $1.00 the employer contributed.
Galephar Pharmaceutical Research Inc's 2023 employer contribution ran below the $522 median for plans its size. Filings report dollars actually contributed, not the match formula; the formula itself (for example, 50% of the first 6% of pay) lives in the plan's summary plan description from HR.
Annual cost at the plan's reported 2023 administrative ratio, against the median plan its size; fund expense ratios are extra. Compare any plan.
Compensation shown is direct payments from plan assets reported on Schedule C. Providers paid through fund revenue-sharing appear as indirect.
Why are you looking at this plan?
Source: U.S. Department of Labor, Form 5500 series, EIN 660965645 · Verify on EFAST2 · Amounts are as reported by the plan sponsor for the plan year shown.